Table 3.
Prior hepatitis C treatment regimens for patients treated in GI vs. PCP clinic.
| Prior treatment | GI clinic (noncirrhotic) Group-1 (n = 192) | PCP clinic (noncirrhotic) Group-2 (n = 185) | p value |
|---|---|---|---|
| Treatment naïve, n (%) | 149 (77.60) | 172 (92.97) | <0.01 |
| Previous treatment, n (%) | 43 (22.40) | 13 (7.03) | |
| Interferon+ribavirin | 33 (17.19) | 11 (5.95) | <0.01 |
| PEG/ribavirin/boceprevir | 5 (2.60) | 1 (0.54) | |
| Harvoni & ribavirin | 4 (2.08) | 0 | |
| Viekira Pak+ribavirin | 0 | 1 (0.54) | |
| Interferon | 1 (0.52) | 0 |
Abbreviations: GI: gastroenterology; PCP: primary care physician; PEG: pegylated interferon alpha.